Cited by 63Cardiovascular Disease and AdiposityAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability

Open access
Li, Biao, Po, Sunny S., Zhang, Baojian, Bai, Fan, Li, Jiayi, Qin, Fen, Liu, Na, Sun, Chao +4 more·2020·Journal of Cellular and Molecular Medicine

Abstract

Abstract Epicardial adipose tissue (EAT) remodelling is closely related to the pathogenesis of atrial fibrillation (AF). We investigated whether metformin (MET) prevents AF‐dependent EAT remodelling and AF vulnerability in dogs. A canine AF model was developed by 6‐week rapid atrial pacing (RAP), and electrophysiological parameters were measured. Effective refractory periods (ERP) were decreased in the left and right atrial appendages as well as in the left atrium (LA) and right atrium (RA). MET attenuated the RAP‐induced increase in ERP dispersion, cumulative window of vulnerability, AF inducibility and AF duration. RAP increased reactive oxygen species (ROS) production and nuclear factor kappa‐B (NF‐κB) phosphorylation; up‐regulated interleukin‐6 (IL‐6), tumour necrosis factor‐α (TNF‐α) and transforming growth factor‐β1 (TGF‐β1) levels in LA and EAT; decreased peroxisome proliferator‐activated receptor gamma (PPARγ) and adiponectin (APN) expression in EAT and was accompanied by atrial fibrosis and adipose infiltration. MET reversed these alterations. In vitro , lipopolysaccharide (LPS) exposure increased IL‐6, TNF‐α and TGF‐β1 expression and decreased PPARγ/APN expression in 3T3‐L1 adipocytes, which were all reversed after MET administration. Indirect coculture of HL‐1 cells with LPS‐stimulated 3T3‐L1 conditioned medium (CM) significantly increased IL‐6, TNF‐α and TGF‐β1 expression and decreased SERCA2a and p‐PLN expression, while LPS + MET CM and APN treatment alleviated the inflammatory response and sarcoplasmic reticulum Ca 2+ handling dysfunction. MET attenuated the RAP‐induced increase in AF vulnerability, remodelling of atria and EAT adipokines production profiles. APN may play a key role in the prevention of AF‐dependent EAT remodelling and AF vulnerability by MET.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jcmm.15407

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, B., Po, S. S., Zhang, B., Bai, F., Li, J., Qin, F., Liu, N., Sun, C., Xiao, Y., Tu, T., Zhou, S., & Liu, Q.
Affiliations
  • Central South University (CN)
  • University of Oklahoma Health Sciences Center (US)
Corresponding author
Liu, Qiming
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2020-05-22
Volume
24
Issue
14
Pages
7751-7766
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W3026964594
Cited by
63
References
60
Citations by year
2026: 8 · 2025: 12 · 2024: 13 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 2
FWCI
4.49
Type
journal article
Language
en
Open access
Locations
  • Journal of Cellular and Molecular Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81570310,, 81770337, 81600273)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
metformin, adiponectin, epicardial adipose tissue, atrial fibrillation, atrial remodeling, atrial fibrosis, atrial pacing, effective refractory period, inflammatory cytokines, PPARγ, reactive oxygen species, NF-κB, SERCA2a, phospholamban, lipopolysaccharide, canine model
MeSH terms
Adipose Tissue, Animals, Atrial Fibrillation, Calcium, Disease Models, Animal, Disease Susceptibility, Dogs, Electrocardiography, Metformin, Pericardium, Signal Transduction, Biomarkers, Cytokines, Reactive Oxygen Species, Adipocytes, Inflammation Mediators, Myocytes, Cardiac, 3T3-L1 Cells, Mice, Adiponectin, Atrial Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review